(Q46941754)

26 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts (English)

1 reference

26 December 2017

1 reference

1 reference

6

Fazlul H Sarkar

1 reference

26 December 2017

Omer Kucuk

5

object named as

Omer Kucuk

1 reference

26 December 2017

author name string

Ramzi M Mohammad

1

1 reference

26 December 2017

Sanjeev Banerjee

2

1 reference

26 December 2017

Yiwei Li

3

1 reference

26 December 2017

Amro Aboukameel

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

106

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

1260-1268

1 reference

26 December 2017

Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Genistein inhibits NF-kappa B activation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Free radicals, antioxidant enzymes, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

Gene expression profiles of genistein-treated PC3 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

p53-independent apoptosis induced by genistein in lung cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

The role of isoflavones in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21731

7 January 2021

Genistein, a specific inhibitor of tyrosine-specific protein kinases

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/CNCR.21731

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/CNCR.21731

Early NF-kappaB activation is associated with hormone-induced pancreatitis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/CNCR.21731

Identifiers

DOI

10.1002/CNCR.21731

1 reference

26 December 2017

1 reference

26 December 2017